
David Whelan
David Whelan is a co-founder and general partner of Town Hall Ventures, a health care firm focused on underserved patients. He sits on the board of Thyme Care, valued at $1.1B, and helped start Town Hall companies such as Eleanor Health and Suvida Healthcare.
- Founded
- Suvida Healthcare, Empassion Health, Eleanor Health +4 more
- Backed
- Strive Health, Cityblock Health, Concert Health +4 more
- Education
- South East Technological University, Bond University
Track record
Investments David Whelan is best known for, with what became of them.
- TThyme CareBoard member; Town Hall co-led a 2023 roundValued at $1.1B
- CCityblock HealthInvestor, per DealroomValued at $6.3B
- SStrive HealthInvestor; Town Hall invested in 2018Valued at $1B–2.5B, per Dealroom
- EEleanor HealthCo-founder and board memberValued at $250M–500M, per Dealroom
Town Hall Ventures
Career
- Earned law and commerce degrees from Bond University in Australia.
- Worked as an investment banker at Goldman Sachs in London and Sydney.
- Led corporate development at Virgin Group, including the launch of Virgin America.
- Served as CFO and general partner of Accretive and as managing general partner of the Oxeon venture studio.
- 2018Co-founded Town Hall Ventures with Andy Slavitt and Trevor Price.
- 2025Town Hall raised a $440M fourth fund.
Sources: Dealroom: David Whelan · Forbes via InsuranceNewsNet: $440M fund · Twin Cities Business: Town Hall's first investments · Dealroom: Thyme Care. Rank: 2026 Strebulaev–Jackson Venture Ranking.
Investments 7
Companies backed, as recorded by Dealroom. Highest company valuations first.







Companies founded







Currently
Active roles, board seats and partnerships.








Work history
Past roles by Dealroom records.





Education

